Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 2 June 2022
Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment
Press Release, 31 May 2022
Kuros Biosciences announces favorable preliminary results of MagnetOs as standalone alternative to autograft in first randomized controlled trial
Press Release, 18 May 2022
Kuros Biosciences announces commercial launch of MagnetOs Easypack Putty in the U.S.
Press Release, 27 April 2022
Kuros Biosciences continues strong commercial roll-out of MagnetOs bone graft
Press Release, 21 April 2022
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences’s MagnetOs Flex Matrix Cleared by FDA for Spinal Indications
Press Release, 16 March 2022
Kuros Biosciences reports results for the full year 2021